Rapid Micro Biosystems logo
RPIDRapid Micro Biosystems
Trade RPID now
Rapid Micro Biosystems primary media

About Rapid Micro Biosystems

Rapid Micro Biosystems (NASDAQ:RPID) specializes in providing innovative solutions aimed at automating the microbial detection and enumeration process for pharmaceutical and personal care products manufacturing. Their main focus is on enhancing productivity, quality, and compliance within the life sciences industry through their flagship product, the Growth Direct™ system. This system revolutionizes traditional microbial quality control methods by significantly reducing the time needed to detect contamination, thereby accelerating product release times and improving manufacturing efficiency. Rapid Micro Biosystems' objective is to disrupt the conventional microbial testing market by bringing speed, accuracy, and data integrity to quality control laboratories worldwide, ultimately ensuring safer products reach consumers more quickly.

What is RPID known for?

Snapshot

Public US
Ownership
2006
Year founded
193
Employees
Lowell, United States
Head office
Loading Map...

Operations

All Locations
Lowell, US

Produtos e/ou serviços de Rapid Micro Biosystems

  • The Growth Direct system automates rapid microbial detection, enhancing pharmaceutical manufacturing efficiency and safety through faster quality control testing.
  • Environmental Monitoring applications of the Growth Direct system provide automated, rapid detection of environmental contaminants in manufacturing areas, ensuring compliance with regulatory standards.
  • Sterility Testing solutions by the Growth Direct system offer rapid, automated testing for pharmaceutical products, significantly reducing the time to release sterile products to market.
  • Bioburden Testing services utilize the Growth Direct system for fast, automated detection of microbial contamination in raw materials, in-process samples, and finished products.
  • Data Management and Reporting tools integrated with the Growth Direct system offer real-time, efficient data analysis and reporting capabilities, improving decision-making and compliance.
  • Service and Support for the Growth Direct system ensure optimal performance and uptime, including installation, training, maintenance, and troubleshooting, enhancing customer satisfaction and trust.

equipe executiva do Rapid Micro Biosystems

  • Mr. Robert G. Spignesi Jr.CEO, President & Director
  • Mr. Sean M. Wirtjes CPAChief Financial Officer
  • Mr. John J. Addington WilsonChief Operating Officer
  • Mr. Michael Beaulieu C.F.A.Vice President of Investor Relations & Corporate Communications
  • Mr. James XuSenior VP of Legal & Secretary
  • Ms. Julie JarvieSenior VP of Human Resources

Conecte-se conosco

A Grafa não é um consultor financeiro. Você deve buscar aconselhamento independente, jurídico, financeiro, tributário ou de outra natureza que se relacione às suas circunstâncias únicas.

A Grafa não se responsabiliza por qualquer perda causada, seja por negligência ou de outra forma, decorrente do uso ou da confiança nas informações fornecidas direta ou indiretamente pelo uso desta plataforma.